Abstract
Effect of lamivudine treatment on plasma levels of transforming growth factor beta 1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have